BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22167612)

  • 1. [Immunotherapy mechanisms in glomerulonephritis].
    Polci R; Feriozzi S
    G Ital Nefrol; 2011; 28(6):612-21. PubMed ID: 22167612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
    Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
    An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
    Nigam R; Levitt J
    J Drugs Dermatol; 2012 May; 11(5):622-5. PubMed ID: 22527431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and management of small vessel vasculitides].
    Pettersson T; Karjalainen A
    Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and future therapies for lupus nephritis.
    Appel GB
    Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
    Hoffman GS
    Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of rituximab in primary and secondary glomerulonephritis].
    Insalaco M; Zanoli L; Fatuzzo P; Fiorini F; Granata A
    G Ital Nefrol; 2015; 32(6):. PubMed ID: 26845209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 9. New treatment strategies in idiopathic nephrotic syndrome.
    Ulinski T; Aoun B
    Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest treatment strategies for membranous nephropathy.
    Ruggenenti P; Cravedi P; Remuzzi G
    Expert Opin Pharmacother; 2007 Dec; 8(18):3159-71. PubMed ID: 18035960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of post-transplant glomerulonephritis].
    Sandrini S; Valerio F
    G Ital Nefrol; 2008; 25 Suppl 44():99-106. PubMed ID: 19048593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in the treatment of lupus nephritis.
    Fanouriakis A; Krasoudaki E; Tzanakakis M; Boumpas DT
    Mod Rheumatol; 2012 Nov; 22(6):803-13. PubMed ID: 22584472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].
    Passerini P; Scolari F; Frasca' GM; Leoni A; Venturelli C; Dallera N; Ravera S; Balestra E; Freddi P; Fanciulli E; D'Arezzo M; Sagripanti S
    G Ital Nefrol; 2009; 26(5):563-76. PubMed ID: 19802802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
    Yang T; Nast CC; Vo A; Jordan SC
    Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: an introduction].
    Feriozzi S
    G Ital Nefrol; 2012; 29(3):267-73; discussion 292. PubMed ID: 22718449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with rituximab for a patient with p-ANCA glomerulonephritis, alveolar bleeding and multiple relapses during haemodialysis].
    Azancot MA; Agraz Pamplona I; Fort Ros J; Marín Valencia A; Gil Carballeira I; Camps Domenech J
    Nefrologia; 2010; 30(6):710-2. PubMed ID: 21113230
    [No Abstract]   [Full Text] [Related]  

  • 17. Refractory bullous pemphigoid with fatal outcome in a young patient.
    Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
    Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
    Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
    Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic tests and treatment options in glomerular disease: 2014 update.
    Hogan J; Mohan P; Appel GB
    Am J Kidney Dis; 2014 Apr; 63(4):656-66. PubMed ID: 24239051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent news in the treatment of lupus nephritis.
    Tesar V; Hruskova Z
    Minerva Med; 2012 Aug; 103(4):235-51. PubMed ID: 22805617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.